Letter to the Editor

Subacute Combined Degeneration of the Spinal Cord in a Young African-American Man

Authors: Costas Michaelides, MD, MRCP (UK), Janice F. Wiesman, MD

Abstract

Subacute combined degeneration (SCD) of the spinal cord arises from deficiency of cobalamin and may be induced by pernicious anemia (PA) which typically affects patients of Northern European ancestry and tends to occur in the sixth decade of life. We recently cared for a 27-year-old African-American man who presented with numbness of the fingers bilaterally and progressive gait deterioration for six months. He experienced electric-like shocks extending down the spine upon flexing his head (L'Hermitte's sign) intermittently. He was a smoker and consumed moderate amounts of alcohol. His diet was normal and contained animal products, and there was no family or personal history of gastrointestinal or neurologic disease. On examination, his tongue was beefy. His power was mildly decreased at the iliopsoas bilaterally. His reflexes were diminished at the ankles but normal elsewhere, and he had extensor plantar responses. Sensory examination revealed decreased cold sensation in the feet. Vibratory and joint position sensations were decreased in the toes. Romberg's maneuver was positive. His gait was spastic. White blood cell count was 3.1 k/μL (4.0–11.0), hemoglobin 11.7 G/dL (13.5–18), mean corpuscular volume 123 FL (80–96) and his platelet count 68 K/μL. (150–400). Vitamin B12level was 157 pg/mL (211–911). Furthermore, he had a low thyroid stimulating hormone at 0.23 μIU/mL (0.35–5.50) with positive thyroid peroxidase antibodies (16.2 IU/mL) but normal T4, T3 uptake and free T4 index. Positive serum anti-intrinsic factor antibodies were found. Magnetic resonance imaging of the brain and cervical spine was normal. He was treated with a series of five 1000 μg vitamin B12 IM injections and with monthly ones thereafter. His symptoms started improving as early as three weeks into the treatment.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Akinyanju OO, Okany CC. Pernicious anaemia in Africans. Clin Lab Haematol 1992;14:33–40.
 
2. Solanki DL, Jacobson RJ, Green R, et al. Pernicious anemia in blacks. A study of 64 patients from Washington, D. C., and Johannesburg, South Africa. Am J Clin Pathol. 1981;75:96–99.
 
3. Carmel R. Ethnic and racial factors in cobalamin metabolism and its disorders. Semin Hematol1999;36:88–100.
 
4. Carmel R, Ozturk G, Johnson CS, et al. Profiles of black and Latin-American patients having pernicious anemia. HLA antigens, lymphocytotoxic antibody, anti-parietal cell antibody serum gastrin levels, and ABO blood groups. Am J Clin Pathol 1981;75:291–296.
 
5. De Block CE De Leeuw IH Van Gaal LF. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J Clin Endocrinol Metab 1999;84:4062–4067.